GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2

Predictive value of low interleukin-33 in critically ill patients

(2018) Konstantin A. Krychtiuk et al.   CYTOKINE

Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years

(2017) Thomas Pezawas et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation

(2017) Bernhard Wernly et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention

(2017) Yan-Peng Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets

(2017) Stefan Stojkovic et al.   THROMBOSIS AND HAEMOSTASIS

Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure

(2017) Abhinav Sharma et al.   JACC-Heart Failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Diagnostic performance and reference values of novel biomarkers of paediatric heart failure

(2016) Jakob A Hauser et al.   HEART

The Diagnosis and Evaluation of Dilated Cardiomyopathy

(2016) Alan G. Japp et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

(2016) Stefan Stojkovic et al.   Scientific Reports

ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel

(2015) James L. Januzzi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Soluble ST2 in heart failure

(2015) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

(2015) Silvia G. Priori et al.   EUROPEAN HEART JOURNAL

Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure

(2015) Kaspar Broch et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   European Heart Journal-Cardiovascular Imaging

Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction

(2015) Antonio Lax et al.   JACC-Heart Failure

Multiple Autonomic and Repolarization Investigation of Sudden Cardiac Death in Dilated Cardiomyopathy and Controls

(2014) Thomas Pezawas et al.   Circulation-Arrhythmia and Electrophysiology

Interleukin-33 induces urokinase in human endothelial cells―possible impact on angiogenesis

(2014) S. Stojkovic et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome

(2014) Svitlana Demyanets et al.   PLoS One

Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure

(2014) Tariq Ahmad et al.   JACC-Heart Failure

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

(2013) Clyde W. Yancy et al.   CIRCULATION

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature

(2013) Svitlana Demyanets et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support

(2012) Sjoukje I. Lok et al.   EUROPEAN JOURNAL OF HEART FAILURE

Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques

(2011) Svitlana Demyanets et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers

(2011) P. A. Scott et al.   EUROPACE

Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure

(2010) Inder S. Anand et al.   CIRCULATION

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dilated cardiomyopathy

(2010) John Lynn Jefferies et al.   LANCET

Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling

(2009) Kenjiro Seki et al.   Circulation-Heart Failure

Delayed-Enhanced Magnetic Resonance Imaging in Nonischemic Cardiomyopathy

(2009) Frank M. Bogun et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

(2009) Domingo A. Pascual-Figal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY